NEUROENDOCRINE NEOPLASMS

Clinical trials for NEUROENDOCRINE NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE NEOPLASMS trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet finished but already full! 1 Completed 1

Scientists test new Two-Pronged attack on Tough-to-Treat cancers

Disease control Ongoing

This early-stage study is testing a new combination of two drugs, obrixtamig and ezabenlimab, in adults with advanced small cell lung cancer or other neuroendocrine tumors that have a specific marker called DLL3. The main goal is to find the highest dose of the combination that p…

Matched conditions: NEUROENDOCRINE NEOPLASMS

Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

NEUROENDOCRINE NEOPLASMS

Get alerted when new NEUROENDOCRINE NEOPLASMS trials appear

Scientists test new Two-Pronged attack on Tough-to-Treat cancers